Durgical
EN
Open the app

Soluble guanylate cyclase (sGC) stimulators

Drugs that switch on the nitric oxide receptor in blood vessels, raising cGMP and relaxing them. Used in pulmonary hypertension and heart failure.

Updated

What they are

Riociguat (pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension) and vericiguat (heart failure with reduced ejection fraction).

Mechanism of action

Soluble guanylate cyclase is the receptor for nitric oxide: it makes cGMP, which relaxes smooth muscle. sGC stimulators bind the enzyme at a site separate from NO, stimulate it directly and make it more sensitive to the little NO that is present, which matters when NO is lacking.

Target: Soluble guanylate cyclase (NO receptor)

Drugs in this class

Test yourself

Think of the answer, then tap the question to see it.

Why are sGC stimulators contraindicated with sildenafil or nitrates?

All raise cGMP: nitrates via NO, PDE-5 inhibitors by slowing its breakdown, so the combination causes severe hypotension.

How does an sGC stimulator differ from a nitrate?

A nitrate supplies NO; an sGC stimulator acts on the enzyme directly, at its own site, and sensitizes it to NO.

Which two conditions does riociguat treat?

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (CTEPH).

Add to my cards (3)

More Pharmacology questions →

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Riociguat: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2023); DailyMed - RIOCIGUAT tablet, film coated (DailyMed (U.S. National Library of Medicine), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.